Carbidopa and Levodopa
Active substance: CARBIDOPA, LEVODOPA
CAPSULE, EXTENDED RELEASE · CARBIDOPA 23.75 mg/1, LEVODOPA 95 mg/1
United StatesActive
Marketing holder: Zydus Pharmaceuticals USA Inc.
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
Composition
- CARBIDOPA · 23.75 mg/1
- LEVODOPA · 95 mg/1
Registration
- Registration number
- 70710-2139
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- ORAL
Sources
- product · openFDA NDC · 70710-2139 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 70710-2139 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 70710-2139 · Verified 2026-10-09 · open in source
- ingredients.1 · openFDA NDC · 70710-2139 · Verified 2026-10-09 · open in source